KEYWORD TOPIC

Moderna's Hantavirus Vaccine Development | Institutional Investors Adjust Moderna (MRNA) Holdings: A Summary of Recent Transactions | Earnings Live: Exxon, Chevron Oil Output Boosts Profits, Moderna Stock Tumbles, Amazon Sinks | Moderna's Hantavirus Vaccine Development | Institutional Investors Adjust Moderna (MRNA) Holdings: A Summary of Recent Transactions | Earnings Live: Exxon, Chevron Oil Output Boosts Profits, Moderna Stock Tumbles, Amazon Sinks

Healthcare / Vaccines

Moderna's Hantavirus Vaccine Development

Moderna (MRNA) has announced that it is in the early stages of developing a vaccine for the hantavirus. This development comes amid renewed interest in the virus and has led to a ~14% increase in Moderna's stock in Friday afternoon trading....

May 08, 2026 18:31 Hantavirus: What to Know About the Virus—and Why Moderna Stock Rallied

Moderna's Hantavirus Vaccine Development

Image via Barron's

TOPIC moderna stock

Financial / Stock Market

Institutional Investors Adjust Moderna (MRNA) Holdings: A Summary of Recent Transactions

Recent SEC filings reveal significant activity in Moderna (MRNA) stock by institutional investors. This article summarizes these transactions, providing insights into institutional sentiment towards the biotechnology company. Understanding...

Aug 06, 2025 12:00 ABC Arbitrage SA Takes Position in Moderna, Inc. (NASDAQ:MRNA)

Finance / Earnings

Earnings Live: Exxon, Chevron Oil Output Boosts Profits, Moderna Stock Tumbles, Amazon Sinks

A look at the recent earnings reports from major companies, highlighting key takeaways and market reactions. Several companies have released their Q2 earnings reports, leading to various stock movements.

Aug 04, 2025 14:32 Earnings live: Exxon, Chevron oil output boosts profits, Moderna stock tumbles, Amazon sinks